Discover how we are championing this cause, together.
Learn about the progress being made across the country and in your own backyard.
Canadian innovation in ovarian cancer research can save the lives of women in Canada and around the world
Every 5 hours, we lose someone we love to ovarian cancer in Canada. Ovarian cancer is the most fatal women’s cancer and sadly, one in two diagnosed do not live to see another five years.
Ovarian Cancer Canada and the Quebec-Clinical Research Organization in Cancer team up to improve access to vital resources
Ovarian Cancer Canada and the Quebec-Clinical Research Organization in Cancer (Q-CROC) are teaming up to optimize the support available to women affected by ovarian cancer in Quebec.
July 28, 2021
Expanding horizons in ovarian cancer research
A new partnership between Ovarian Cancer Canada and the Cancer Research Society recently announced funding for 10 new projects testing treatments that show potential to help people with this disease live longer and better.
June 15, 2021
Enabling research on rare forms of ovarian cancer
Dr. Mark Carey is developing scientific models to advance research on low-grade serous cancer, a rare form of the disease.
April 6, 2021
IRICoR and Ovarian Cancer Canada announce $2.3M
IRICoR and Ovarian Cancer Canada announce $2.3M for development of new treatments for ovarian cancer
March 30, 2021
$1.35 million for ovarian cancer research
The Cancer Research Society and Ovarian Cancer Canada are proud to jointly launch a competition to fund some of Canada’s most promising research projects focused on ovarian cancer. The competition will award up to 6 grants, each totaling $225,000 over a two-year period.
February 23, 2021
The benefits of 3D models in ovarian cancer research
These will enable scientists to test new treatments, leading to new clinical trials, and ultimately improved outcomes for women with this disease.
November 18, 2020
OvCAN Patient Partners inform research with their lived experience
OvCAN Patient Partners have important roles in a wide range of activities, from reviewing clinical trial funding applications to sharing their lived experience directly with ovarian cancer researchers and scientists.
November 2, 2020
Researchers examine new drug target with potential to improve treatment
Dr. Kirk McManus and Dr. Mark Nachtigal's collaborative research project was recently awarded two years’ joint funding from Ovarian Cancer Canada and the Cancer Research Society.
September 23, 2020
Making Waves in Research: OvCAN Update
Four OvCAN-funded clinical trials happening across Canada will provide a wide range of new insights.
May 27, 2020
Paving the way for research breakthroughs
Allen Zhang receives 2020 Anita Unruh Prize